STOCK TITAN
  1. Home
  2. Sec-filings
  3. CDRE
  4. [Form 4] Cadre Holdings, Inc. Insider Trading Activity

Cadre Holdings (NYSE: CDRE) president sells 88K shares after exercising options

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Cadre Holdings, Inc. (CDRE) reported that its President, Brad Williams, exercised stock options and sold shares on August 17, 2026. He exercised options covering 88,742 shares of Common Stock at exercise prices of $23.45 and $20.53 per share under the company’s 2021 Stock Incentive Plan. The transactions resulted in the acquisition of 42,770 and 45,972 shares of Common Stock, with 107,851 shares reported as directly owned immediately after one of the exercises. On the same date he sold a total of 88,742 shares of Common Stock in open-market transactions at weighted average prices of $34.34 (range $34.25–$34.38) and $33.24 (range $33.02–$33.66) per share. The filing indicates these trades were not made pursuant to a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Williams Brad
Role PRESIDENT
Sold 88,742 shs ($2.95M)
Approx. gross sale proceeds $2.95M
Approx. exercise cost $1.95M
Approx. pre-tax spread $1.00M
Type Security Shares Price Value
Exercise Stock Option (right to purchase) F3 42,770 $0.00 $0.00
Exercise Stock Option (right to purchase) F4 45,972 $0.00 $0.00
Exercise Common Stock, par value $0.0001 per share ("Common Stock") 42,770 $23.45 $1.00M
Exercise Common Stock 45,972 $20.53 $944K
Sale Common Stock F1 104 $34.34 $4K
Sale Common Stock F2 88,638 $33.24 $2.95M
Holdings After Transaction: Stock Option (right to purchase) — 0 shares (Direct); Common Stock, par value $0.0001 per share ("Common Stock") — 107,851 shares (Direct); Common Stock — 65,081 shares (Direct)
Footnotes (4)
  1. F1. The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $34.25 to $34.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.
  2. F2. The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $33.02 to $33.66 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.
  3. F3. The option to purchase shares of the Issuer's Common Stock was granted under the Issuer's 2021 Stock Incentive Plan (the "Plan"). Options to purchase 14,256 shares of the Issuer's Common Stock vested and became exercisable on March 9, 2023, and options to purchase 14,257 shares of the Issuer's Common Stock vested and became exercisable on each of March 9, 2024 and March 9, 2025.
  4. F4. The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 15,324 shares of the Issuer's Common Stock vested and became exercisable on each of March 13, 2024, March 13, 2025 and March 13, 2026.
Options Exercised at $23.45 42,770 shares Stock options exercised at a conversion price of $23.45 per share on August 17, 2026
Options Exercised at $20.53 45,972 shares Stock options exercised at a conversion price of $20.53 per share on August 17, 2026
Total Shares Exercised 88,742 shares Sum of derivative exercises (M code) reported in the Form 4
Shares Sold at $34.34 104 shares Weighted average sale price $34.34; actual trades ranged from $34.25 to $34.38
Shares Sold at $33.24 88,638 shares Weighted average sale price $33.24; actual trades ranged from $33.02 to $33.66
Total Shares Sold 88,742 shares Net sell shares across S-code transactions on August 17, 2026
Shares Owned After One Exercise 107,851 shares Directly owned Common Stock reported following the 42,770-share acquisition
Option Expiration Dates March 9, 2032; March 13, 2033 Expiration dates for the exercised stock options under the 2021 Stock Incentive Plan
Stock Option (right to purchase) financial
"security_title: Stock Option (right to purchase)"
weighted average price per share financial
"The price reported in Column 4 is a weighted average price per share."
2021 Stock Incentive Plan financial
"granted under the Issuer's 2021 Stock Incentive Plan (the "Plan")."
vested and became exercisable financial
"Options to purchase shares ... vested and became exercisable on March 9, 2023"

FAQ

What insider transactions did CDRE President Brad Williams report on August 17, 2026?
Brad Williams exercised options for 88,742 shares of Cadre Holdings (CDRE) Common Stock and sold 88,742 shares the same day. The option exercises used strike prices of $23.45 and $20.53 per share under the 2021 Stock Incentive Plan.

At what prices did Brad Williams sell Cadre Holdings (CDRE) shares on August 17, 2026?
He sold CDRE shares at weighted average prices of $34.34 and $33.24 per share. Footnotes state the actual trades occurred in ranges of $34.25–$34.38 and $33.02–$33.66, respectively, across multiple transactions.

How many Cadre Holdings (CDRE) options did Brad Williams exercise and at what strike prices?
He exercised options covering 88,742 shares of CDRE Common Stock. These included 42,770 shares at a strike price of $23.45 and 45,972 shares at a strike price of $20.53, all granted under the 2021 Stock Incentive Plan.

How many Cadre Holdings (CDRE) shares did Brad Williams report owning after the option exercise?
Following the acquisition of 42,770 shares upon one option exercise, Brad Williams reported 107,851 shares of CDRE Common Stock held directly. The filing does not state a consolidated post-sale total across all transactions reported that day.

Were Brad Williams’ August 17, 2026 Cadre Holdings (CDRE) trades under a Rule 10b5-1 plan?
No. The Form 4 for Cadre Holdings (CDRE) shows the Rule 10b5-1 checkbox as not checked. The footnotes do not indicate any separate trading plan, so the transactions are not identified as being under a pre-arranged Rule 10b5-1 plan.

What plan governed the stock options Brad Williams exercised in Cadre Holdings (CDRE)?
The options were granted under Cadre Holdings’ 2021 Stock Incentive Plan. Footnotes specify vesting in annual tranches, with portions becoming exercisable on March 9, 2023–2025 and March 13, 2024–2026 before the reported August 17, 2026 exercises.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Brad
(Last)(First)(Middle)
C/O CADRE HOLDINGS, INC.
13386 INTERNATIONAL PKWY
(Street)
JACKSONVILLE FLORIDA 32218
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Cadre Holdings, Inc. [ CDRE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
PRESIDENT
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.0001 per share ("Common Stock")08/17/2026M42,770A$23.45107,851D
Common Stock08/17/2026M45,972A$20.53153,823D
Common Stock08/17/2026S104D$34.34(1)153,719D
Common Stock08/17/2026S88,638D$33.24(2)65,081D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to purchase)$23.4508/17/2026M42,770 (3)03/09/2032Common Stock42,770$00D
Stock Option (right to purchase)$20.5308/17/2026M45,972 (4)03/13/2033Common Stock45,972$00D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $34.25 to $34.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.
2. The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $33.02 to $33.66 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth in this footnote.
3. The option to purchase shares of the Issuer's Common Stock was granted under the Issuer's 2021 Stock Incentive Plan (the "Plan"). Options to purchase 14,256 shares of the Issuer's Common Stock vested and became exercisable on March 9, 2023, and options to purchase 14,257 shares of the Issuer's Common Stock vested and became exercisable on each of March 9, 2024 and March 9, 2025.
4. The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 15,324 shares of the Issuer's Common Stock vested and became exercisable on each of March 13, 2024, March 13, 2025 and March 13, 2026.
/s/ Brad Williams08/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR